Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Siegel™ Transcatheter Aortic Valve Replacement System (TAVR) Early Feasibility Study

NCT06680427 is registered in ClinicalTrials.gov with MiRus as lead sponsor.

NCT NCT06680427
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06680427 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Siegel™ Transcatheter Aortic Valve Replacement System (TAVR) Early Feasibility Study
Lead sponsor
MiRus
Phase
Not applicable
Overall status
Active, not recruiting
Start date
March 26, 2025
Completion date
December 31, 2025
Enrollment
30 (estimated)
Sites
8

Conditions

As the registry lists them; a condition with its own page is linked.

aortic stenosis symptomatic